Cargando…

Sunitinib Malate Synergistically Potentiates Anti-Tumor Effect of Gemcitabine in Human Bladder Cancer Cells

PURPOSE: Sunitinib malate (Sutent; Pfizer, New York, NY, USA) is a highly selective multi-targeted agent and has been reported to have potent anti-tumor effects against various tumors, including renal cell carcinoma and gastrointestinal stromal tumors. In this study, we explored in vitro the anti-tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Cheol Yong, Lee, Jung Sun, Kim, Bo Sun, Jeong, Seong Jin, Hong, Sung Kyu, Byun, Seok Soo, Lee, Sang Eun
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037508/ https://www.ncbi.nlm.nih.gov/pubmed/21344032 http://dx.doi.org/10.4111/kju.2011.52.1.55

Ejemplares similares

Synergistic Effect between Cisplatin and Sunitinib Malate on Human Urinary Bladder-Cancer Cell Lines
por: Arantes-Rodrigues, Regina, et al.
Publicado: (2013)

Guillain-Barré Syndrome following Treatment with Sunitinib Malate
por: Kanaan, Ziad, et al.
Publicado: (2014)

M1 macrophage-derived exosomes synergistically enhance the anti- bladder cancer effect of gemcitabine
por: Tang, Zhiling, et al.
Publicado: (2022)

NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells
por: MOON, DU G., et al.
Publicado: (2014)

Limited Expression of Cytochrome P450 17α-Hydroxylase/17,20-Lyase in Prostate Cancer Cell Lines
por: Jeong, Chang Wook, et al.
Publicado: (2011)

Vesicocutaneous fistula formation during treatment with sunitinib malate: Case report
por: Watanabe, Koichiro, et al.
Publicado: (2010)

Human urothelial carcinoma cell response to Sunitinib malate therapy in vitro
por: Wen, Jin, et al.
Publicado: (2015)

In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients
por: Mey, V, et al.
Publicado: (2006)

Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate
por: Gasent Blesa, Joan Manel, et al.
Publicado: (2009)

Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines
por: Kim, Sung Han, et al.
Publicado: (2016)

Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer
por: Tomko, Andrea M., et al.
Publicado: (2022)

Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients
por: Numakura, Kazuyuki, et al.
Publicado: (2018)

Effective Antiviral Activity of the Tyrosine Kinase Inhibitor Sunitinib Malate against Zika Virus
por: Lin, Chen-Sheng, et al.
Publicado: (2021)

Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma
por: Hwang, Hyun Ji, et al.
Publicado: (2022)

External Validation of Models for Prediction of Lymph Node Metastasis in Urothelial Carcinoma of the Bladder
por: Ku, Ja Hyeon, et al.
Publicado: (2015)

Angiosarcoma of the Retroperitoneum: Report on a Patient Treated with Sunitinib
por: Yoo, Changhoon, et al.
Publicado: (2009)

Preoperative erectile function and the pathologic features of prostate cancer
por: Jeong, Chang Wook, et al.
Publicado: (2015)

The Long-Term Influence of Body Mass Index on the Success Rate of Mid-Urethral Sling Surgery among Women with Stress Urinary Incontinence or Stress-Predominant Mixed Incontinence: Comparisons between Retropubic and Transobturator Approaches
por: Jeong, Seong Jin, et al.
Publicado: (2014)

Do additional cores from cancer-suspicious lesions on transrectal ultrasound improve prostate cancer detection including index tumors over 12-core systematic biopsy?
por: Jo, Jung Ki, et al.
Publicado: (2018)

A case of metastatic renal cell carcinoma treated effectively by gemcitabine and sunitinib
por: Morizane, Shuichi, et al.
Publicado: (2012)

Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer
por: Seo, Ho Kyung, et al.
Publicado: (2014)

Impact of Tamsulosin on Ureter Stone Expulsion in Korean Patients: A Meta-Analysis of Randomized Controlled Studies
por: Lee, Jung Keun, et al.
Publicado: (2012)

Boosting the Anticancer Activity of Sunitinib Malate in Breast Cancer through Lipid Polymer Hybrid Nanoparticles Approach
por: Ahmed, Mohammed Muqtader, et al.
Publicado: (2022)

Magnetic solid phase extraction of Sunitinib malate in urine samples assisted with mixed hemimicelle and spectrophotometric detection
por: Pourbasheer, Eslam, et al.
Publicado: (2023)

Clinical benefits of retrograde bladder filling method prior to catheter removal after TURP for BPH: A prospective randomized trial
por: Song, Sang Hun, et al.
Publicado: (2022)

Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib
por: Kim, Myung Soo, et al.
Publicado: (2018)

Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical Treatment
por: Lee, Hakmin, et al.
Publicado: (2016)

Prevalence and Clinical Features of Detrusor Underactivity among Elderly with Lower Urinary Tract Symptoms: A Comparison between Men and Women
por: Jeong, Seong Jin, et al.
Publicado: (2012)

Impact of poor glycemic control upon clinical outcomes after radical prostatectomy in localized prostate cancer
por: Lee, Hakmin, et al.
Publicado: (2021)

Association of long noncoding RNA MALAT1 polymorphisms with gastric cancer risk in Korean individuals
por: Hong, Jang Hee, et al.
Publicado: (2020)

Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study
por: Michaelson, M D, et al.
Publicado: (2013)

Clinical Value of Core Length in Contemporary Multicore Prostate Biopsy
por: Lee, Sangchul, et al.
Publicado: (2015)

Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy
por: Lee, Hakmin, et al.
Publicado: (2018)

A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate
por: O’Farrell, Alice C., et al.
Publicado: (2017)

Oral administration of sunitinib malate for long-term survival of a patient with multiple lung metastases from renal leiomyosarcoma
por: Li, Xiaoyan, et al.
Publicado: (2016)

Preoperative therapy with sunitinib malate in a patient with a gastrointestinal stromal tumor and liver metastases: A case report
por: Wang, Zhi-Qiang, et al.
Publicado: (2019)

Sunitinib Treatment for Metastatic Renal Cell Carcinoma in Patients with Von Hippel-Lindau Disease
por: Kim, Ho Cheol, et al.
Publicado: (2013)

Alteration of Antithrombin III and D-dimer Levels in Clinically Localized Prostate Cancer
por: Hong, Sung Kyu, et al.
Publicado: (2010)

Mobile Application-Based Seoul National University Prostate Cancer Risk Calculator: Development, Validation, and Comparative Analysis with Two Western Risk Calculators in Korean Men
por: Jeong, Chang Wook, et al.
Publicado: (2014)

Preoperative Serum Sex Hormone-Binding Globulin Level Is an Independent Predictor of Biochemical Outcome After Radical Prostatectomy
por: Lee, Jung Keun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_keo4sc7tgohv3irc1dfhqvje11